Capital Bank & Trust’s Zimmer Biomet ZBH Stock Holding History

Capital Bank & Trust’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-176,012	Closed	-$27.5M	–	198
2021 Q2	$27.5M	Buy	176,012 +9,042	+5%	+$1.46M	0.32%	87
2021 Q1	$25.9M	Buy	166,970 +5,581	+3%	+$865K	0.31%	86
2020 Q4	$24.1M	Buy	+161,389	New	+$22.8M	0.29%	89
2020 Q2	–	Sell	-618	Closed	-$61K	–	683
2020 Q1	$61K	Hold	618	–	–	﹤0.01%	390
2019 Q4	$90K	Sell	618 -37	-6%	-$5.11K	﹤0.01%	373
2019 Q3	$87K	Buy	655 +37	+6%	+$4.78K	﹤0.01%	379
2019 Q2	$71K	Sell	618 -147	-19%	-$17.2K	﹤0.01%	394
2019 Q1	$95K	Buy	765 +147	+24%	+$16.7K	﹤0.01%	347
2018 Q4	$62K	Hold	618	–	–	﹤0.01%	394
2018 Q3	$79K	Hold	618	–	–	﹤0.01%	393
2018 Q2	$67K	Sell	618 -127	-17%	-$13.8K	﹤0.01%	392
2018 Q1	$79K	Hold	745	–	–	﹤0.01%	350
2017 Q4	$87K	Hold	745	–	–	﹤0.01%	370
2017 Q3	$85K	Hold	745	–	–	﹤0.01%	338
2017 Q2	$93K	Buy	+745	New	+$88.3K	﹤0.01%	316

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Bank & Trust's ZBH Position: Q3 2021 in Review

Capital Bank & Trust sold out of Zimmer Biomet (ZBH) in Q3 2021, closing a stake of 176,012 shares — an estimated $27.5M sold.

Capital Bank & Trust first reported a position in ZBH in Q2 2017 and held it in 15 quarters. The position peaked at $27.5M in Q2 2021. 982 funds tracked by Wall St. Rank hold ZBH as of Q3 2021.

Capital Bank & Trust reported no remaining Zimmer Biomet position as of Q3 2021 after selling out during the quarter.
Capital Bank & Trust sold 176,012 Zimmer Biomet shares in Q3 2021, an estimated $27.5M.
Capital Bank & Trust first reported a position in Zimmer Biomet in Q2 2017 and held it in 15 quarters.
Capital Bank & Trust's Zimmer Biomet position peaked at $27.5M in Q2 2021.
982 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2021.

Based on Capital Bank & Trust's 13F filing for Q3 2021, filed 15 Nov 2021.